Table of Contents
Organic Chemistry International
Volume 2011, Article ID 614627, 5 pages
http://dx.doi.org/10.1155/2011/614627
Research Article

Synthesis of [2′-(N-Ethylamino)-5′-Alkyl]phenyl-5,6,7,8-Tetrahydroacridine-9-Carboxy-2-Sulfone Derivatives by the Proton-Catalyzed Rearrangement of Corresponding Sulfonamides

Department of Chemistry, Banasthali University, Banasthali, Rajasthan 304022, India

Received 5 October 2011; Accepted 14 December 2011

Academic Editor: Ken Shimizu

Copyright © 2011 Anamika Sharma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. P. Becker, T. E. Barta, L. Bedell et al., “α-amino-β-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1,” Bioorganic and Medicinal Chemistry Letters, vol. 11, no. 20, pp. 2719–2722, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Bader, J. F. Hoops, J. H. Biel, H. H. Koelling, R. G. Stein, and T. Singh, “Antimalarial compounds related to diaminodiphenyl sulfone,” Journal of Medicinal Chemistry, vol. 12, no. 4, pp. 709–711, 1969. View at Google Scholar · View at Scopus
  3. W. A. Petri Jr., “Antimicrobial agents,” in Goodman Gilman’s The Pharmacological Basis of Therapeutics, J. G. Hardman, L. E. Limbird, and A. G. Gilman, Eds., pp. 1171–1189, McGraw-Hill, 10th edition, 2001. View at Google Scholar
  4. D. J. Abraham, Ed., Burger’s Medicinal Chemistry and Drug Discovery, vol. 5, 6th edition, 2003.
  5. T. Triglia, J. G. T. Menting, C. Wilson, and A. F. Cowman, “Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 25, pp. 13944–13949, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. M. J. Freyche, “Antibiotics and sulfonamides in the treatment of trachoma,” Bulletin of the World Health Organization, vol. 2, no. 4, pp. 523–544, 1950. View at Google Scholar · View at Scopus
  7. P. Iliades, S. R. Meshnick, and I. G. Macreadie, “Mutations in the Pneumocystis jirovecii DHPS gene confer cross-resistance to sulfa drugs,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 2, pp. 741–748, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Iliades, S. R. Meshnick, and I. G. Macreadie, “Analysis of Pneumocystis jirovecii DHPS alleles implicated in sulfamethoxazole resistance using an Escherichia coli model system,” Microbial Drug Resistance, vol. 11, no. 1, pp. 1–8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. C. C. Shepard, R. M. Van Landingham, and L. L. Walker, “Recent studies of antileprosy drugs (special issue),” Leprosy Review, vol. 54, pp. 23s–30s, 1983. View at Google Scholar · View at Scopus
  10. C. C. Shepard, L. Levy, and P. Fasal, “The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment,” The American Journal of Tropical Medicine and Hygiene, vol. 18, no. 2, pp. 258–263, 1969. View at Google Scholar · View at Scopus
  11. M. Artico, R. Silvestri, S. Massa et al., “2-sulfonyl-4-chloroanilino moiety: a potent pharmacophore for the anti-human immunodeficiency virus type 1 activity of pyrrolyl aryl sulfones,” Journal of Medicinal Chemistry, vol. 39, no. 2, pp. 522–530, 1996. View at Google Scholar · View at Scopus
  12. M. Artico, R. Silvestri, E. Pagnozzi et al., “Structure-based design, synthesis, and biological evaluation of novel pyrrolyl aryl sulfones: HIV-1 non-nucleoside reverse transcriptase inhibitors active at nanomolar concentrations,” Journal of Medicinal Chemistry, vol. 43, no. 9, pp. 1886–1891, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. W. A. Denny, “Acridine derivatives as chemotherapeutic agents,” Current Medicinal Chemistry, vol. 9, no. 18, pp. 1655–1665, 2002. View at Google Scholar · View at Scopus
  14. A. Adams, “Crystal structures of acridines complexed with nucleic acids,” Current Medicinal Chemistry, vol. 9, no. 18, pp. 1667–1675, 2002. View at Google Scholar · View at Scopus
  15. M. Demeunynck, F. Charmantray, and A. Martelli, “Interest of acridine derivatives in the anticancer chemotherapy,” Current Pharmaceutical Design, vol. 7, no. 17, pp. 1703–1724, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Charmantray, M. Demeunynck, D. Carrez et al., “4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents,” Journal of Medicinal Chemistry, vol. 46, no. 6, pp. 967–977, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. T.-L. Su, T.-C. Chou, J. Y. Kim et al., “9-substituted acridine derivatives with long half-life and potent antitumor activity: synthesis and structure-activity relationships,” Journal of Medicinal Chemistry, vol. 38, no. 17, pp. 3226–3235, 1995. View at Google Scholar
  18. N. S. Burres, S. Sazesh, G. P. Gunawardana, and J. J. Clement, “Antitumor activity and nucleic acid binding properties of dercitin, a new acridine alkaloid isolated from a marine Dercitus species sponge,” Cancer Research, vol. 49, no. 19, pp. 5267–5274, 1989. View at Google Scholar · View at Scopus
  19. N. Greenhalgh, R. Hull, and E. W. Hurst, “The antiviral activity of acridines in eastern equine encephalomyelitis, rift valley fever and psittacosis in mice, and lymphogranuloma venereum in chick-embryos,” British Journal of Pharmacology and Chemotherapy, vol. 11, no. 2, p. 220, 1956. View at Google Scholar
  20. A. Crémieux, J. Chevalier, D. Sharples et al., “Antimicrobial activity of 9-oxo and 9-thio acridines: correlation with intercalation into DNA and effects on macromolecular biosynthesis,” Research in Microbiology, vol. 146, no. 1, pp. 73–83, 1995. View at Publisher · View at Google Scholar
  21. N. Motohashi, H. Sakagami, T. Kurihara, L. Ferenczy, K. Csuri, and J. Molnar, “Antimicrobial activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines,” Anticancer Research, vol. 12, no. 4, pp. 1207–1210, 1992. View at Google Scholar · View at Scopus
  22. N. V. Novosad, “The antimicrobial activity of thio-, thioxo- and oxo- derivatives of acridine,” Mikrobiol Z, vol. 58, no. 4, p. 55, 1996. View at Google Scholar
  23. V. A. Shibnev, M. P. Finogenova, L. N. Grinberg, and A. M. Allakhverdiev, “Synthesis of acridine derivatives of amino acid hydrazines and their antimalarial activity,” Bioorganicheskaia Khimiia, vol. 14, no. 11, pp. 1565–1569, 1988. View at Google Scholar · View at Scopus
  24. S. M. Sondhi, G. Bhattacharjee, R. K. Jameel et al., “Antiinflammatory, analgesic and kinase inhibition activities of some acridine derivatives,” Central European Journal of Chemistry, vol. 2, no. 1, pp. 1–15, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. O. N. Witt and D. Uermenyi, “Untersuchungen über substituierte Aryl-sulfamide,” Chemische Berichte, vol. 46, p. 296, 1913. View at Google Scholar · View at Scopus
  26. A. R. Katritzky and A. J. Boulton, Advances in Heterocyclic Chemistry, vol. 18, Acadamic Press, New York, NY, USA, 1975.
  27. A. R. Gennaro and M. Zanger, “1,2,3,4-Tetrahydroquinoline 8-sulfones,” Journal of Organic Chemistry, vol. 36, no. 9, pp. 1321–1324, 1971. View at Google Scholar · View at Scopus